GHK-Cu

GHK-Cu (also known as Copper peptide GHK) is a prominently researched experimental compound classified strictly within the Copper Peptide framework. Operating primarily through advanced pharmacological pathways, it functions by copper delivery for collagen/elastin synthesis. Activates tissue remodeling, attracts immune cells to injury sites. Levels decline significantly with age. with a documented biological half-life of roughly 0.5 hours, in preclinical investigative trials and independent academic studies, researchers utilizing GHK-Cu have documented significant, quantifiable biological outcomes, primarily focusing on skin repair, anti-aging, wound healing. Typical research protocols investigate administering 2000 to 2000mcg via subq pathways 7x/wk. However, it is critically important to understand that while GHK-Cu demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.